FIA
LUNG icon

FNY Investment Advisers’s Pulmonx LUNG Stock Holding History

FNY Investment Advisers’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,500
Closed -$76K – 962
2025
Q4 		$76K Buy
34,500
+16,134
+88% +$30.3K 0.02% 381
2025
Q3 		$29K Buy
+18,366
New +$38.4K 0.01% 619

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Investment Advisers's LUNG Position: Q1 2026 in Review

FNY Investment Advisers sold out of Pulmonx (LUNG) in Q1 2026, closing a stake of 34,500 shares — an estimated $76K sold.

FNY Investment Advisers first reported a position in LUNG in Q3 2025 and held it in 2 quarters. The position peaked at $76K in Q4 2025. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • FNY Investment Advisers reported no remaining Pulmonx position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 34,500 Pulmonx shares in Q1 2026, an estimated $76K.
  • FNY Investment Advisers first reported a position in Pulmonx in Q3 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Pulmonx position peaked at $76K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.